scispace - formally typeset
K

Kim Edelstein

Researcher at Princess Margaret Cancer Centre

Publications -  51
Citations -  1041

Kim Edelstein is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Neurocognitive & Medicine. The author has an hindex of 18, co-authored 42 publications receiving 783 citations. Previous affiliations of Kim Edelstein include University of Toronto & University Health Network.

Papers
More filters
Journal ArticleDOI

Cycle of period gene expression in a diurnal mammal (Spermophilus tridecemlineatus): implications for nonphotic phase shifting.

TL;DR: Ground squirrels, Spermophilus tridecemlineatus, were kept in a 12:12 h light-dark cycle and locomotor activity occurred almost entirely in the daytime, as expected for a diurnal species.
Journal ArticleDOI

Neurobiology of perceptual and motor timing in children with spina bifida in relation to cerebellar volume

TL;DR: Perceptual and motor timing were correlated, suggesting that children with spina bifida meningomyelocele have impairments in a central timing mechanism, and structure-function relations between timing and cerebellar volumes are demonstrated.
Journal ArticleDOI

Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study

TL;DR: Adolescent survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy only were more likely to demonstrate headstrong behaviour and those with learning problems were less likely to graduate from college as young adults than adolescent survivors without cognitive or behaviour problems.
Journal ArticleDOI

Assessing information and service needs of young adults with cancer at a single institution: the importance of information on cancer diagnosis, fertility preservation, diet, and exercise

TL;DR: YA’s have clear supportive care preferences and needs and programs that incorporate the services identified as important should improve quality of life, psychosocial adjustment, and other outcomes during and after cancer therapy.
Journal ArticleDOI

Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.

TL;DR: It is shown that deficits exist many years post treatment even with a relatively lower dose of CRT, and that these deficits are especially evident on tasks involving rapid processing of information.